Resolvyx Pharmaceuticals develops therapeutics with small molecule lipid mediators for the treatment of inflammatory diseases.
Business Model:
Revenue: $9.5M
Employees: 11-50
Address: 222 3rd St
City: Cambridge
State: MA
Zip: 02142
Country: US
Resolvyx Pharmaceuticals is developing an entirely new class of medicines called Resolvins. Resolvins are naturally-occurring, small molecule lipid mediators with the potential to treat a wide range of inflammatory diseases. Unlike most anti-inflammatory drugs which suppress the body&s;s inflammatory response, Resolvins work by activating the body&s;s own mechanisms for shutting off, or resolving, inflammation.
Contact Phone:
+17815415045
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2005 | Series A | 3 | $17M |
Atlas Venture CHL Medical Partners Flagship Pioneering Atlas Venture CHL Medical Partners Flagship Pioneering |
11/2010 | Venture Round | $2.5M | 6/2010 | Debt Financing | $1.2M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|